Inhibitory effect of rice bran-derived crude glycosphingolipid on colon preneoplastic biomarker lesions induced by azoxymethane in male F344 rats

Molecular Medicine Reports

Volumn 2, Issue 1, 2009, Pages 45-49

  Sunagawa, Nao ^a   Inamine, Morihiko ^a   Morioka, Takamitsu ^a   Chiba, Itaru ^a   Morita, Nanae ^a   Aoki, Yoichi ^a   Suzui, Masumi ^b   Yoshimi, Naoki ^a  

^a UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Colon; Glycosphingolipid; Preneoplastic lesions; Prevention; Rice bran

Indexed keywords

ALCOHOL; AZOXYMETHANE; CASPASE 3; CYCLINE; GLYCOSPHINGOLIPID; MUCIN;

ABERRANT CRYPT FOCI LESION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN DETECTION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL DESTRUCTION; CANCER INHIBITION; CELL PROLIFERATION; COLON CARCINOGENESIS; COLON MUCOSA; COLON TUMOR; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG ISOLATION; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIUM CELL; MALE; MUCIN DEPLETED FOCI LESION; NONHUMAN; PRECANCER; PROTEIN CLEAVAGE; RAT; RICE BRAN; TREATMENT DURATION;

RATTUS;

EID: 69249150465     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr-00000060     Document Type: Article

References (29)

1. Okazaki T, Bielawska A, Bell RM and Hannun YA: Role of ceramide as a lipid mediator of 1 alpha,25-dihydroxyvitamin D3-induced HL-60 cell differentiation. J Biol Chem 265: 15823-15831, 1990. (Pubitemid 20310991)
2. Riboni L, Prinetti A, Bassi R, Caminiti A and Tettamanti G: A mediator role of ceramide in the regulation of neuroblastoma Neuro2a cell differentiation. J Biol Chem 270: 26868-26875, 1995.
3. Obeid LM, Linardic CM, Karolak LA and Hannun YA: Programmed cell death induced by ceramide. Science 259: 1769-1771, 1993. (Pubitemid 23114667)
4. Cifone MG, De Maria R, Roncaioli P, et al: Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med 180: 1547-1552, 1994. (Pubitemid 24289629)
5. Haimovitz-Friedman A, Kan CC, Ehleiter D, et al: Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 180: 525-535, 1994. (Pubitemid 24224129)
6. Bird RP: Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 37: 147-151, 1987.
7. Bird RP: Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 93: 55-71, 1995.
8. Corpet DE and Tache S: Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency. Nutr Cancer 43: 1-21, 2002.
9. Caderni G, Femia AP, Giannini A, et al: Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis. Cancer Res 63: 2388-2392, 2003. (Pubitemid 36605173)
10. Femia AP, Bendinelli B, Giannini A, et al: Mucin-depleted foci have beta-catenin gene mutations, altered expression of its protein, and are dose- and time-dependent in the colon of 1,2-dimethylhydrazine-treated rats. Int J Cancer 116: 9-15, 2005. (Pubitemid 40827749)
11. Yoshimi N, Morioka T, Kinjo T, et al: Histological and immunohistochemical observations of mucin-depleted foci (MDF) stained with Alcian blue, in rat colon carcinogenesis induced with 1,2-dimethylhydrazine dihydrochloride. Cancer Sci 95: 792-797, 2004. (Pubitemid 39545584)
12. Femia AP, Dolara P and Caderni G: Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis. Carcinogenesis 25: 277-281, 2004. (Pubitemid 38239810)
13. Pierre Freeman A, Tache S, van der Meer R and Corpet DE: Beef meat and blood sausage promote the formation of azoxymethane-induced mucin-depleted foci and aberrant crypt foci in rat colons. J Nutr 134: 2711-2716, 2004. (Pubitemid 39315277)
14. Dillehay DL, Webb SK, Schmelz EM and Merrill AH Jr: Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice. J Nutr 124: 615-620, 1994.
15. Schmelz EM, Bushnev AS, Dillehay DL, Liotta DC and Merrill AH Jr: Suppression of aberrant colonic crypt foci by synthetic sphingomyelins with saturated or unsaturated sphingoid base backbones. Nutr Cancer 28: 81-85, 1997.
16. Schmelz EM, Dillehay, DL, Webb SK, Reiter A, Adams J and Merrill AH Jr: Sphingomyelin consumption suppresses aberrant colonic crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1,2-dimethylhydrazine: implications for dietary sphingolipids and colon carcinogenesis. Cancer Res 56: 4936-4941, 1996. (Pubitemid 26374432)
17. Schmelz EM, Sullards MC, Dillehay DL and Merrill AH Jr: Colonic cell proliferation and aberrant crypt foci formation are inhibited by dairy glycosphingolipids in 1,2-dimethylhydrazine-treated CF1 mice. J Nutr 130: 522-527, 2000.
18. Symolon H, Schmelz EM, Dillehay DL and Merrill AH Jr: Dietary soy sphingolipids suppress tumorigenesis and gene expression in 1,2- dimethylhydrazine-treated CF1 mice and ApcMin/+ mice. J Nutr 134: 1157-1161, 2004. (Pubitemid 38619956)
19. Inamine M, Suzui M, Morioka T, et al: Inhibitory effect of dietary monoglucosyl-ceramide 1-O-beta-glucosyl-N-2′-hydroxyarachidoyl-4,8- sphingadienine on two different categories of colon preneoplastic lesions induced by 1,2-dimethylhydrazine in F344 rats. Cancer Sci 96: 876-881, 2005. (Pubitemid 43056126)
20. Hall PA and Woods AL: Immunohistochemical markers of cellular proliferation: achievements, problems and prospects. Cell Tissue Kinet 23: 505-522, 1990.
21. Gown AM and Willingham MC: Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3. J Histochem Cytochem 50: 449-454, 2002.
22. Schmelz EM, Bushnev AS, Dillehay DL, Sullards MC, Liotta DC and Merrill AH Jr: Ceramide-beta-D-glucuronide: synthesis, digestion, and suppression of early markers of colon carcinogenesis. Cancer Res 59: 5768-5772, 1999.
23. Ahn EH and Schroeder JJ: Sphingoid bases and ceramide induce apoptosis in HT-29 and HCT-116 human colon cancer cells. Exp Biol Med 227: 345-353, 2002.
24. Ogretmen B and Hannun YA: Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 4: 604-616, 2004. (Pubitemid 39025055)
25. Yang J, Yu Y, Sun S and Duerksen-Hughes PJ: Ceramide and other sphingolipids in cellular responses. Cell Biochem Biophys 40: 323-350, 2004. (Pubitemid 41270779)
26. Kolesnick R: The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J Clin Invest 110: 3-8, 2002. (Pubitemid 34743457)
27. Heinrich M, Wickel M, Schneider-Brachert W, et al: Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J 18: 5252-5263, 1999. (Pubitemid 29465576)
28. Selzner M, Bielawska A, Morse MA, et al: Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res 61: 1233-1240, 2001. (Pubitemid 32174448)
29. Schmelz EM, Roberts PC, Kustin EM, et al: Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids. Cancer Res 61: 6723-6729, 2001.